With inflation expected to remain high, five Dividend Aristocrats—companies with 25+ years of rising dividends—are recommended for investors seeking stable income and growth. These firms, including AbbVie, Chevron, PepsiCo, Procter & Gamble, and Target, have strong pricing power and resilient business models that help them pass rising costs to consumers. Their consistent dividend growth and defensive sectors make them attractive during economic uncertainty and inflationary pressures. Analysts from major Wall Street firms rate these stocks as Buys, highlighting their potential to outperform in sticky inflation environments.
Investing in three blue-chip dividend stocks—Altria, AbbVie, and Chevron—each paying dividends quarterly on different schedules, can create a monthly income stream throughout the year. Altria pays in January, April, July, and October with a high yiel...
AbbVie has submitted an application to the European Medicines Agency (EMA) for approval of SKYRIZI (risankizumab) as a subcutaneous induction treatment for adults with moderately to severely active Crohn's disease. This follows positive results from ...
AbbVie continues to demonstrate solid revenue and earnings growth driven by the strong performance of Skyrizi and Rinvoq, which compensate for declines in Humira sales. Recent regulatory approvals and expanded market opportunities support the company...
